Skip to main content
OpenTrials

Clinical trial condition

Neuromyelitis Optica

Explore clinical trials studying Neuromyelitis Optica. Study availability and eligibility vary by location and protocol.

127 public trials 43 recruiting studies
Refine in advanced search Browse all conditions

Neuromyelitis Optica trial results

Recruiting

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

NCT06680037

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, B-cell Mediated Autoimmune Disorders, +28 more
Locations
  • TG Therapeutics Investigational Trial Site La Jolla, California, United States
  • TG Therapeutics Investigational Trial Site Ann Arbor, Michigan, United States
  • TG Therapeutics Investigational Trial Site Omaha, Nebraska, United States
  • TG Therapeutics Investigational Trial Site New York, United States
View Trial Details
Recruiting

A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)

NCT05199688

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +11 more
Locations
  • Children's Hospital Colorado. Denver, Colorado, United States
  • Hospital de Pediatría S.A.M.I.C.- Prof. Dr. Juan P. Garrahan Ciudad Autonoma Buenos Aires, Argentina
  • Clinica Universitaria Reina Fabiola Córdoba, Argentina
  • Guangzhou Women and Children's Medical Center Guangzhou, Guangdong, China
View all 13 locations
View Trial Details
Recruiting

Stem Cell Ophthalmology Treatment Study II

NCT03011541

Conditions
Abnormalities, Multiple, Age-Related Macular Degeneration, Autoimmune Diseases, +75 more
Locations
  • MD Stem Cells Westport, Connecticut, United States
  • MD Stem Cells Coral Springs, Florida, United States
  • MD Stem Cells Kobinia Med Vienna, Austria
  • The Saudi-German Hospital Dubai, United Arab Emirates
View Trial Details
Recruiting

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

NCT07526493

Conditions
Anti-Myelin Oligodendrocyte Glycoprotein Immunoglobulin G Antibody-Associated Disease (MOGAD), Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +37 more
Locations
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details
Recruiting

Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)

NCT05145361

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +10 more
Locations
  • Beijing Tiantan Hospital Capital Medical University Beijing, Beijing Municipality, China
  • First Hospital of Shanxi Medical University Taiyuan, Shanxi, China
  • Tangdu hospital,fourth military medical university Xi’an, Shanxi, China
  • Tianjin Medical University General Hospital Tianjin, Tianjin Municipality, China
View Trial Details

Related conditions